Physician Scientist, passion for science, a life devoted to patients care.
Buenos Aires City Region, Argentina
Joined May 2017
- Tweets486
- Following107
- Followers248
- Likes1.4K
Silvia Sookoian retweeted
New online! Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management dlvr.it/TRb1CM
Silvia Sookoian retweeted
Semaglutide for #MASH - metabolic steatohepatitis @AghemoAlessio @SSookoian @LiverInt @policlinicoMI pubmed.ncbi.nlm.nih.gov/4114…
Silvia Sookoian retweeted
Exciting news! "Clinical and Molecular Hepatology" has achieved a 2024 Impact Factor of 16.9, ranking 6th out of 143 in Gastrenterology & Hepatology.
Thank you all for your continued support and contributions. Let’s continue this journey together by advancing knowledge and driving impactful research!
#ResearchCommunity #ImpactFactor #CMH #KASL
Silvia Sookoian retweeted
Avances en la enfermedad conocida como hígado graso.
Científicos del @CONICETDialoga y de UMAI identifican una proteína que asocia la esteatosis hepática, conocida como hígado graso, con complicaciones en órganos vitales. @SSookoian @ValeriaRoman @EduPeriodista @norabar
Silvia Sookoian retweeted
Hoy, en la Academia Nacional de Medicina le entregamos el Doctorado Honoris Causa a Luis Acero, prestigioso médico español especialista en Cirugía Buco Maxilofacial. Participaron de esta ceremonia el Dr. Eduardo Rey, Adrián Giacchino, Lino Barañao, Tomás Ameigeiras y @SSookoian
Silvia Sookoian retweeted
With @ArunJSanyalVCU, @SSookoian, @cjpirola. A call to recognize MASLD/MASH as a NCD. #livertwitter New in @NatRevGastroHep
New online! MASLD as a non-communicable disease bit.ly/3WPHaz0
Silvia Sookoian retweeted
Remember to screen first degree relatives for case finding of advanced #masld @stefano_romeo76 @SSookoian @NASH_and_coffee
#CGH4ALL @AGA_CGH📣
In relatives of pts w/ adv. Fibrosis or HCC 2/2 MASLD:
💡56.8% MASLD Prevalence
💡14.4% adv fibrosis
DM🍭BMI🍐may be some common risk factors
Could not identify polygenic risk factors
🔗doi.org/10.1016/j.cgh.2023.1…
#LiverTwitter #MASLD
Report @talal_khurshid
Silvia Sookoian retweeted
Never underestimate the gut microbiome's potential impact.
New @NatureMedicine
A younger metabolic age gut microbiome counters cardiovascular risk in older adults
nature.com/articles/s41591-0…
Silvia Sookoian retweeted
The first drug approved for MASH, along with the global toll of this disease, summarized (e.g. ~30% of world population w/ MAFLD)
cell.com/cell/fulltext/S0092…
Silvia Sookoian retweeted
#GUTImage from the #RecentAdvancesInClinicalPractice paper by @JonelTrebicka et al entitled "Recent advances in the prevention and treatment of decompensated cirrhosis & ACLF & the role of biomarkers" via bit.ly/3URhCjc
@ruben_hernaez @DebbieShawcros1 @AlexanderGerbes
Silvia Sookoian retweeted
This a picture of Stephen from NASHTag this year or last. 💔 @AleksanderKrag @juanpabloarab @phil_newsome7 @MeenaBBansal @JVLazarus @rabataller @MarcoArreseMD @SSookoian @NASH_and_coffee
With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-harris…
Silvia Sookoian retweeted
Best slide award at the @AASLDtweets #AASLDETC on precision medicine in #MASH goes to @DinaTiniakos
(The science part of the Tal was awesome too)
Silvia Sookoian retweeted
Last day #keystone on MASH. Thanks @stefano_romeo76, @SSookoian, @mcharltonmd and Gregory Tesz for the excellent program
Silvia Sookoian retweeted
Thanks @stefano_romeo76 and @SSookoian for great time and science #keystone. Here with @lucavalenti75, Luca Lotta, Julia Kozlitina, @E_Casirati and Celine Hoffmann
Silvia Sookoian retweeted
Today, we celebrate #InternationalWomensDay at our Emerging Topic Conference (ETC): Precision Medicine in #MASLD by recognizing these amazing women leading the way in #hepatology 🌟 Their expertise and insights shape the future of liver health. #WomenInScience #AASLD #IWD2024
Silvia Sookoian retweeted
In very good company @AASLDtweets! A privilege to be in this distinguished group of women today. @ESP_Pathology @EASLnews @my_ueg @uoaofficial @eemh_hasl @SSookoian #iwd2024 @EqualityNCLUni @LiverPath_HPHS – at Paradise, NV
Today, we celebrate #InternationalWomensDay at our Emerging Topic Conference (ETC): Precision Medicine in #MASLD by recognizing these amazing women leading the way in #hepatology 🌟 Their expertise and insights shape the future of liver health. #WomenInScience #AASLD #IWD2024
Silvia Sookoian retweeted
If you are interested in MASLD and top science this is a must! Plus the Mohntains are spectacular!
Working with a great team to organize @KeystoneSymp #MASH and #Fibrosis: Molecular Phenotypes to #PrecisionTherapeutics, this February! Join us to explore emerging #LiverFibrosis #FattyLiver #NAFLD research in Banff! keysym.us/KSMASH24 #KSMASH24
Silvia Sookoian retweeted
Deadline for Short Talks at Keystone Symposia on MASH and Fibrosis is 28NOV and fast approaching !
Silvia Sookoian retweeted
Nomenclature update to AASLD practice guidance out today! #LiverTwitter @AASLDtweets @KanwalFasiha @DrLoomba @ebtapper @NoureddinMD @juanpabloarab journals.lww.com/hep/citatio…
Silvia Sookoian retweeted
#TLM2023 will start in 2 days! The @AASLDtweets MASLD SIG is pleased to share this MASLD program for your quick reference. See you in Boston soon!
